Erik S.G. Stroes

1991–2026 年に発表

別表記
Erik S. G. Stroes · Erik S G Stroes
266
論文数
63,024
被引用数
120
h 指数
255
i10 指数

被引用数

Erik S.G. Stroes の年別被引用数1985 年: 被引用 3 件1991 年: 被引用 1 件1992 年: 被引用 1 件1996 年: 被引用 4 件1997 年: 被引用 15 件1998 年: 被引用 27 件1999 年: 被引用 34 件2000 年: 被引用 62 件2001 年: 被引用 64 件2002 年: 被引用 92 件2003 年: 被引用 75 件2004 年: 被引用 97 件2005 年: 被引用 109 件2006 年: 被引用 135 件2007 年: 被引用 141 件2008 年: 被引用 199 件2009 年: 被引用 213 件2010 年: 被引用 228 件2011 年: 被引用 240 件2012 年: 被引用 235 件2013 年: 被引用 306 件2014 年: 被引用 325 件2015 年: 被引用 419 件2016 年: 被引用 581 件2017 年: 被引用 571 件2018 年: 被引用 565 件2019 年: 被引用 1,860 件2020 年: 被引用 2,657 件2021 年: 被引用 2,815 件2022 年: 被引用 2,529 件2023 年: 被引用 2,115 件2024 年: 被引用 3,348 件2025 年: 被引用 1,935 件2026 年: 被引用 121 件1986〜1990 年は被引用が無いため表示していません1993〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,244 件、この内訳の 19.6%中国: 引用元論文 2,360 件、この内訳の 8.8%イギリス: 引用元論文 1,737 件、この内訳の 6.5%オランダ: 引用元論文 1,493 件、この内訳の 5.6%イタリア: 引用元論文 1,414 件、この内訳の 5.3%ドイツ: 引用元論文 1,386 件、この内訳の 5.2%カナダ: 引用元論文 1,167 件、この内訳の 4.4%オーストラリア: 引用元論文 912 件、この内訳の 3.4%フランス: 引用元論文 839 件、この内訳の 3.1%スペイン: 引用元論文 769 件、この内訳の 2.9%デンマーク: 引用元論文 546 件、この内訳の 2.1%スイス: 引用元論文 541 件、この内訳の 2%
0%19.6%その他 31.1%

分野

  • Medicine66.9%
  • Biochemistry, Genetics and Molecular Biology21.6%
  • Immunology and Microbiology5.2%
  • Nursing1.3%
  • Neuroscience1%
  • Agricultural and Biological Sciences0.7%
  • その他3.3%

トピック

  • Lipoproteins and Cardiovascular Health10.3%
  • Diabetes, Cardiovascular Risks, and Lipoproteins6%
  • Gut microbiota and health4.8%
  • Atherosclerosis and Cardiovascular Diseases3%
  • Diet and metabolism studies2.6%
  • Cancer, Lipids, and Metabolism2.1%
  • その他71.2%

共著者

全論文

検索で開く
  1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Goran Krstačić, Ekaterini Lambrinou, Basil S. Lewis, Josep Masip, Philippe Moulin, Steffen E. Petersen, Anna Sonia Petronio, Massimo Piepoli, Xavier Pintó, Lorenz Räber, Kausik K. Ray, Željko Reiner, Walter F. Riesen, Marco Roffi, Jean-Paul Schmid, Е. V. Shlyakhto, Iain A Simpson, Erik S.G. Stroes, Isabella Sudano, Alexandros D. Tselepis, Margus Viigimaa, Cécile Vindis, Alexander Vonbank, Michal Vrablik, Mislav Vrsalović, José Luis Zamorano, Jean-Philippe Collet, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G De Backer, Victoria Delgado, Brian A. Ference, Ian M Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R Pedersen, Gabriele Riccardi, Dimitrios J Richter, Marc S. Sabatine, Marja‐Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, Stephan Windecker, Victor Aboyans, Colin Baigent, Jean-Philippe Collet, Verónica Dean, Victoria Delgado, Donna Fitzsimons, Chris P Gale, Diederick E. Grobbee, Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Basil S Lewis, Bela Merkely, Christian Mueller, Steffen E. Petersen, Anna Sonia Petronio, Dimitrios J Richter, Marco Roffi, Е. V. Shlyakhto ほか 54 名 - European Heart Journal 2019 被引用: 8,909

  2. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2022 被引用: 1,297

  3. Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome

    著者: , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2012 被引用: 2,850

  4. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

    著者: , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2021 被引用: 899

  5. Lipoprotein(a) Reduction in Persons with Cardiovascular Disease

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 1,002

  6. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2017 被引用: 1,008

  7. Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

    著者: , , , , , , , , , , , , , , , , , , , - Circulation 2019 被引用: 948

  8. Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

    著者: , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 2,289

  9. Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 669

  10. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2013 被引用: 2,737

  11. Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans

    著者: , , , , , , , , , , , , , , , , , - Circulation 2016 被引用: 656

  12. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

    著者: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2023 被引用: 331

  13. Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels

    著者: , , , , , , , , , , , , , , , - JAMA 2022 被引用: 283

  14. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georgirene D. Vladutiu, Frederick J. Raal, Kausik K. Ray, Michael Roden, Evan A. Stein, Lâle Tokgözoğlu, Børge G. Nordestgaard, Eric Bruckert, Ronald M. Krauss, Ulrich Laufs, Raul D. Santos, Winfried März, Connie B. Newman, M. John Chapman, Henry N. Ginsberg, M. John Chapman, Henry N. Ginsberg, Guy De Backer, Alberico L. Catapano, Robert A. Hegele, G. Kees Hovingh, Terry A. Jacobson, Lawrence A. Leiter, François Mach, Olov Wiklund - European Heart Journal 2015 被引用: 1,420

  15. Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome

    著者: , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 237

  16. Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis

    著者: , , , , , , , , , , , , , - JAMA Cardiology 2021 被引用: 266

  17. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis

    著者: , , , , , , , , , , , , , , - Circulation 2018 被引用: 325

  18. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

    著者: , , , , , , , , , , , , , - The Lancet 2016 被引用: 748

  19. Evinacumab in Patients with Refractory Hypercholesterolemia

    著者: , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 294

  20. Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ulrich Julius, John P. Kane, Michel Krempf, Steven W. Martin, James J. Powell, Richard Shultzaberger, Craig Thompson, Letitia Thompson-Hargrave, Peter P. Tóth, Traci Turner, René Valéro, Bruno Vergès, Frank L.J. Visseren, Pankaj Vyas, Alberto R. Yataco - The Lancet Diabetes & Endocrinology 2021 被引用: 226

  21. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

    著者: , , , , , , , , , - European Journal of Preventive Cardiology 2019 被引用: 360

  22. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease

    著者: , , , , , , , , , - JAMA 2019 被引用: 478

  23. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pablo Corral, Kairat Davletov, Olivier Descamps, Ronen Durst, М. В. Ежов, Dan Gaiță, Jacques Genest, Urh Grošelj, Mariko Harada‐Shiba, Kirsten B. Holven, Meral Kayıkçıoğlu, Weerapan Khovidhunkit, Katarina Lalić, Gustavs Latkovskis, Ulrich Laufs, Evangelos Liberopoulos, Marcos M. Lima-Martínez, Jie Lin, Vincent Maher, Adéle Marais, Winfried März, Erkin М Мirrakhimov, André R. Miserez, Olena Mitchenko, Hapizah Nawawi, Børge G. Nordestgaard, Andrie G. Panayiotou, György Paragh, Žaneta Petrulionienė, Belma Pojskić, Arman Postadzhiyan, Katarı́na Rašlová, Ashraf Reda, Željko Reiner, Fouzia Sadiq, Wilson E. Sadoh, Heribert Schunkert, Aleksandr B. Shek, Mario Stoll, Erik S.G. Stroes, Ta‐Chen Su, Tavintharan Subramaniam, Andrey V. Susekov, Myra Tilney, Brian Tomlinson, Thanh Huong Truong, Alexandros D. Tselepis, Anne Tybjærg‐Hansen, Alejandra Cárdenas, Margus Viigimaa, Luya Wang, Shizuya Yamashita, John J.P. Kastelein, Éric Bruckert, Branislav Vohnout, Laura Schreier, Jing Pang, Christoph Ebenbichler, Hans Dieplinger, Reinhold Innerhofer, Yvonne Winhofer-Stöckl, Susanne Greber‐Platzer, Konstantin A. Krychtiuk, Walter S. Speidl, Hermann Toplak, Kurt Widhalm, Thomas M. Stulnig, Kurt Huber, Florian Höllerl, Gersina Rega‐Kaun ほか 624 名 - The Lancet 2021 被引用: 305

  24. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance

    著者: , , , , , , , - Journal of the American Heart Association 2019 被引用: 433